Therefore, this study aimed to detect polymorphisms in the PCSK9 gene and compare disease severity among participants clinically diagnosed with FH, who either carried polymorphisms or not, at an outpatient clinic of a public tertiary hospital in Southeastern Brazil. This evidence concerns the gene PCSK9 and familial hyperaldosteronism.